Local pharmacists said current tariff policies will make drugs more expensive and harder to find for consumers.

Pharmaceutical tariffs, as proposed by President Donald Trump, aim to create manufacturing jobs in the United States, limit ...

Celltrion Inc., a leading South Korean biopharmaceutical company, said Thursday its business will remain largely unaffected ...

Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Singapore is negotiating with the U.S. to ease tariffs on pharmaceuticals and secure access to advanced chips amid shifting ...

Global pharmaceutical company Pfizer (NYSE:PFE) in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The ...

Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...

Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...